The 5 alpha-reductase in the brain: molecular aspects and relation to brain function

Area of Science:

• Neuroendocrinology
• Steroid Metabolism
• Cellular Neuroscience

Background:

• Hormonal steroids (androgens, estrogens, progestagens, corticosteroids) significantly affect the brain, but mechanisms are not fully understood.
• Steroid actions can be genomic (via intracellular receptors) or extragenomic (involving cell membranes).
• Many steroids require metabolic transformation into active forms within target tissues.

Purpose of the Study:

• To analyze the 5 alpha-reductase-3 alpha-(3 beta)-hydroxysteroid dehydrogenase pathway, a key steroid-transforming system in the brain.
• To investigate the cellular localization and regulation of this enzymatic system in the central nervous system (CNS).
• To explore the potential role of 5 alpha-reduced steroid metabolites in myelination.

Main Methods:

• Detailed analysis of the 5 alpha-reductase-3 alpha-(3 beta)-hydroxysteroid dehydrogenase enzymatic pathway.
• Examination of enzyme distribution across CNS structures and developmental stages.
• Isolation and culture of specific brain cells (neurons, astrocytes, oligodendrocytes) for activity analysis.

Main Results:

• The 5 alpha-reductase-3 alpha-hydroxysteroid dehydrogenase system is widespread in the CNS and not regulated by castration or steroid administration.
• High concentrations of 5 alpha-reductase are found in white matter, associated with myelin membranes.
• Neurons show higher activity in converting testosterone to dihydrotestosterone (DHT) compared to glial cells; only neurons possess aromatase activity.

Conclusions:

• The 5 alpha-reductase pathway is a significant system for steroid metabolism in the brain, particularly associated with myelin.
• 5 alpha-reduced steroid metabolites may play a role in myelination processes.
• Differential activity of steroid-metabolizing enzymes exists between neurons and glial cells.